샘플 요청 목록

 카트 문의
시장보고서
상품코드
1774955

세계의 혈관내 스텐트 시장

Intravascular Stents
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 462 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

혈관내 스텐트 세계 시장은 2030년까지 408억 달러에 달할 전망

2024년에 280억 달러로 추정되는 혈관내 스텐트 세계 시장은 2024-2030년 분석 기간 동안 CAGR 6.5%로 성장하여 2030년에는 408억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 약물 용출 스텐트는 CAGR 6.6%를 기록하며 분석 기간 종료시에는 265억 달러에 달할 것으로 예측됩니다. 일반 금속 스텐트 부문의 성장률은 분석 기간 CAGR로 6.4%로 추정됩니다.

미국 시장은 76억 달러로 추정, 중국은 CAGR 10.2%로 성장 예측

미국의 혈관내 스텐트 시장은 2024년에 76억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 84억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 10.2%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 3.2%와 6.3%로 예측됩니다. 유럽에서는 독일이 CAGR 4.3%로 성장할 것으로 예측됩니다.

세계의 혈관내 스텐트 시장 - 주요 동향과 촉진요인 정리

혈관내 스텐트가 심혈관 치료의 진화의 중심에 있는 이유는 무엇일까?

혈관내 스텐트는 관상동맥질환(CAD) 및 말초혈관질환 관리에서 수술적 중재에 대한 최소침습적 대안으로 각광받고 있습니다. 이 작은 그물망 모양의 관 모양의 기구는 혈관을 지지하고 혈관성형술 후 동맥의 개통성을 유지하기 위해 사용됩니다. 심혈관계 질환은 여전히 전 세계 사망원인 1위로, 효과적이고 내구성 있는 치료 옵션에 대한 수요가 혈관내 스텐트 시장의 성장을 견인하고 있습니다. 기술 혁신, 생활습관병 유병률 증가, 말초혈관 및 신경혈관 적응증 확대 등이 시장 성장의 주요 요인으로 작용하고 있습니다.

중요한 트렌드는 베어메탈스텐트(BMS)에서 약물 용출스텐트(DES)와 생체흡수성스텐트(BRS)로의 전환입니다. 재협착을 예방하는 항증식제를 방출하는 DES는 스텐트 내 재협착 발생률이 낮고 장기 예후가 개선되어 BMS를 대체하고 있습니다. 생체흡수성 스텐트는 아직 도입 초기 단계에 있지만, 시간이 지나면 녹아 없어지는 일시적인 발판을 제공함으로써 차세대 혈관 인터벤션 기술을 대표합니다. 또한, 스텐트 전달 시스템, 코팅 기술, 맞춤형 스텐트 사이징의 발전으로 시술 성공률이 향상되어 보다 광범위한 혈관 질환에 대한 사용이 확대되고 있습니다.

재료와 디자인의 혁신이 임상 결과를 어떻게 개선하고 있는가?

혈관내 스텐트의 진화는 재료 과학과 장치 공학의 급속한 발전에 의해 추진되고 있습니다. 스텐트 구조에 코발트 크롬 합금이나 백금 크롬 합금을 사용함으로써 반경 방향의 강도, 영상 하에서의 가시성, 굴곡성이 향상되어 굴곡진 혈관의 해부학적 구조를 탐색하는 데 필수적인 요소로 작용합니다. 이러한 재료는 또한 더 얇은 지지대를 허용하고, 혈관 외상을 줄이고, 내피의 치유를 촉진합니다. 이와 함께 차세대 DES 플랫폼은 약물 방출 후 분해되는 생흡수성 폴리머 코팅을 특징으로 하여, 패머넌트 폴리머에 따른 장기적인 염증과 혈전 형성의 위험을 최소화합니다.

신경혈관 및 말초혈관 시장에서는 니티놀(니켈-티타늄 합금)로 만든 자가 확장형 스텐트가 초탄성 특성과 혈관 동역학에 적응하는 능력으로 인기를 끌고 있습니다. 또한, 혈관내 초음파(IVUS) 및 광간섭단층촬영(OCT)과 같은 영상 기술의 통합으로 스텐트 삽입의 정확도가 향상되어 최적의 배치와 확장을 보장합니다. 나노기술 기반의 코팅 및 유전자 용출 스텐트에 대한 연구도 진행 중이며, 약물전달 효율을 개선하고 스텐트 말기 혈전증 등의 한계를 극복하기 위해 노력하고 있습니다. 이러한 발전은 최소침습적 혈관 치료의 가능성을 재정의하고 있습니다.

어떤 치료 분야와 사용 사례가 채택을 주도하고 있는가?

관상동맥 질환은 여전히 혈관내 스텐트 사용의 가장 큰 부분을 차지하고 있으며, 전 세계 시술의 대부분을 차지하고 있습니다. 허혈성 심장질환의 확산은 당뇨병, 비만, 고혈압의 유병률 증가와 함께 선진국 시장과 신흥국 시장 모두에서 치료 건수를 증가시키고 있습니다. 혈관내 스텐트는 보다 유연하고 전달하기 쉬운 스텐트 플랫폼으로 인해 분지, 만성 완전폐색, 길고 넓은 미만성 병변과 같은 복잡한 병변에 더 많이 사용되고 있습니다. 이러한 혁신을 통해 인터벤션 심장전문의는 이전에는 스텐트 삽입에 적합하지 않았던 고위험군 환자군까지 치료를 확대할 수 있게 되었습니다.

관상동맥에 대한 적용뿐만 아니라, 말초동맥질환(PAD)은 특히 고령화된 환자층에서 주목도가 높아지고 있는 분야입니다. 자가 확장형 스텐트는 대퇴 슬와 동맥과 장골 동맥에 널리 사용되고 있으며, 생역학적 스트레스가 큰 혈관에서 장기적인 개통성을 제공합니다. 신경혈관용 스텐트는 뇌동맥류 및 허혈성 뇌졸중 치료, 특히 혈전제거 기기와 함께 사용하는 경우가 많아지고 있습니다. 이처럼 관상동맥, 말초, 신경혈관 각 영역에서 사용 사례가 확대됨에 따라 대응 가능한 시장 규모가 확대될 뿐만 아니라, 다양한 혈관 환경에 맞는 특수한 디자인의 스텐트에 대한 수요도 증가하고 있습니다.

임상적, 기술적, 지역적 측면에서 시장 성장을 촉진하는 요인은 무엇인가?

혈관내 스텐트 시장의 성장은 임상 수요, 기술 혁신 파이프라인, 의료 인프라 확장과 관련된 몇 가지 요인에 의해 주도되고 있습니다. 가장 큰 원동력 중 하나는 세계 인구의 고령화와 이에 따른 심혈관 및 말초혈관 질환의 증가입니다. 이러한 인구통계학적 변화는 특히 외래 환자 및 외래 진료 현장에서 스텐트와 같은 최소침습적이고 효과적인 치료 솔루션에 대한 지속적인 수요를 창출하고 있습니다. 동시에 전 세계 헬스케어 산업은 가치 중심으로 전환하고 있으며, 재원일수를 최소화하고 합병증 발생률을 낮추며 장기적인 결과를 개선하는 치료법을 선호하고 있습니다.

또 다른 중요한 성장 요인은 의료기기 업체들의 차세대 스텐트 플랫폼에 대한 지속적인 연구개발 투자입니다. 약물 용출 기술, 생체흡수성 소재, AI를 통합한 스텐트 계획 도구에 집중함으로써 경쟁이 치열한 시장에서 차별화를 도모하고 있습니다. 또한, 아시아태평양, 라틴아메리카, 중동 지역의 의료 접근성 및 카테터 검사실의 급속한 확장은 시술 건수 증가에 기여하고 있습니다. 개선된 진료비 보상, 유리한 임상 가이드라인, 의사 교육 프로그램 등이 이 지역에서의 채택을 더욱 촉진하고 있습니다. 이러한 임상적, 기술적, 구조적 촉진요인의 융합은 세계 혈관내 스텐트 시장의 지속적이고 강력한 성장의 발판을 마련하고 있습니다.

부문

유형(약물 용출, 베어메탈, 생체흡수성), 제공 방식(자가확장형, 풍선확장형), 제품 유형(관상동맥, 말초, 신경혈관), 최종사용자(병원·심장 센터, 외래 수술 센터, 기타)

조사 대상 기업 사례

  • Abbott Laboratories
  • Alvimedica
  • Asahi Intecc Co., Ltd.
  • B. Braun Melsungen AG
  • Biosensors International Group
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • C. R. Bard(now part of BD)
  • Cardinal Health(Cordis)
  • Cook Medical
  • Johnson & Johnson
  • Medinol Ltd.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • OrbusNeich Medical
  • STENTYS SA
  • Terumo Corporation
  • Terumo Interventional Systems

AI 통합

우리는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.08.01

Global Intravascular Stents Market to Reach US$40.8 Billion by 2030

The global market for Intravascular Stents estimated at US$28.0 Billion in the year 2024, is expected to reach US$40.8 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. Drug Eluting Stents, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$26.5 Billion by the end of the analysis period. Growth in the Bare Metal Stents segment is estimated at 6.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.6 Billion While China is Forecast to Grow at 10.2% CAGR

The Intravascular Stents market in the U.S. is estimated at US$7.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$8.4 Billion by the year 2030 trailing a CAGR of 10.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Intravascular Stents Market - Key Trends & Drivers Summarized

Why Are Intravascular Stents Central to the Evolution of Cardiovascular Treatment?

Intravascular stents have become a cornerstone in the management of coronary artery disease (CAD) and peripheral vascular disorders, offering a minimally invasive alternative to surgical interventions. These small mesh-like tubular devices are used to support blood vessels and maintain arterial patency after angioplasty procedures. With cardiovascular diseases remaining the leading cause of death globally, the demand for effective and durable treatment options is driving the expansion of the intravascular stents market. Technological innovation, growing prevalence of lifestyle diseases, and expanded indications in peripheral and neurovascular applications are among the key contributors to market growth.

A significant trend is the transition from bare-metal stents (BMS) to drug-eluting stents (DES) and bioresorbable scaffolds (BRS). DES, which release antiproliferative drugs to prevent restenosis, have largely replaced BMS due to their lower rate of in-stent restenosis and improved long-term outcomes. Bioresorbable stents, although still in early phases of adoption, represent the next generation of vascular intervention technologies by offering temporary scaffolding that dissolves over time. Additionally, advancements in stent delivery systems, coating technologies, and personalized stent sizing are improving procedural success rates and expanding usage across a broader range of vascular conditions.

How Are Innovations in Materials and Design Elevating Clinical Outcomes?

The evolution of intravascular stents is being driven by rapid progress in materials science and device engineering. The use of cobalt-chromium and platinum-chromium alloys in stent construction has enhanced radial strength, visibility under imaging, and flexibility-critical for navigating tortuous vascular anatomies. These materials also allow thinner struts, which reduce vessel trauma and promote faster endothelial healing. In parallel, new-generation DES platforms feature bioabsorbable polymer coatings that degrade after drug release, minimizing long-term inflammation and thrombogenic risk associated with permanent polymers.

In neurovascular and peripheral vascular markets, self-expanding stents made of nitinol (nickel-titanium alloy) are gaining traction due to their superelastic properties and ability to adapt to vessel dynamics. Moreover, the integration of imaging technologies such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT) is enhancing stent placement accuracy, ensuring optimal apposition and expansion. Research into nanotechnology-based coatings and gene-eluting stents is also underway, aiming to improve drug delivery efficiency and address limitations like late stent thrombosis. These advances are redefining what’s possible in minimally invasive vascular therapy.

Which Therapeutic Segments and Use Cases Are Driving Adoption?

Coronary artery disease remains the largest segment for intravascular stent use, accounting for the bulk of global procedures. The widespread prevalence of ischemic heart disease, combined with the rising incidence of diabetes, obesity, and hypertension, is fueling procedural volumes in both developed and emerging markets. Intravascular stents are increasingly being used in complex lesions, such as bifurcations, chronic total occlusions, and long diffuse lesions, thanks to more flexible and deliverable stent platforms. These innovations allow interventional cardiologists to expand treatment to high-risk patient groups that were previously unsuitable for stenting.

Beyond coronary applications, peripheral artery disease (PAD) is a growing area of focus, particularly in aging populations. Self-expanding stents are widely used in the femoropopliteal and iliac arteries, providing long-term patency in vessels subject to high biomechanical stress. Neurovascular stents are also seeing increased deployment in the treatment of cerebral aneurysms and ischemic stroke, especially in conjunction with thrombectomy devices. These expanded use cases across coronary, peripheral, and neurovascular domains are not only increasing total addressable market size but also driving demand for specialized stent designs tailored to different vascular environments.

What’s Fueling the Market Growth Across Clinical, Technological, and Regional Dimensions?

The growth in the intravascular stents market is driven by several factors related to clinical demand, innovation pipelines, and expanding healthcare infrastructure. One of the most significant drivers is the aging global population and the associated rise in cardiovascular and peripheral vascular conditions. This demographic shift is creating sustained demand for less invasive, high-efficacy treatment solutions like stents, particularly in outpatient and ambulatory care settings. Concurrently, the global healthcare industry is moving toward value-based care, favoring interventions that minimize hospital stays, reduce complication rates, and improve long-term outcomes-attributes that intravascular stents are well-positioned to deliver.

Another key growth factor is the ongoing R&D investment by medical device companies in next-generation stent platforms. The focus on drug-eluting technology, bioresorbable materials, and AI-integrated stent planning tools is fostering differentiation in an otherwise competitive market. Additionally, the rapid expansion of healthcare access and catheterization labs in Asia-Pacific, Latin America, and the Middle East is contributing to higher procedural volumes. Reimbursement improvements, favorable clinical guidelines, and physician training programs are further supporting adoption in these regions. The convergence of these clinical, technological, and structural drivers is setting the stage for sustained and robust growth in the global intravascular stents market.

SCOPE OF STUDY:

The report analyzes the Intravascular Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Drug Eluting Stents, Bare Metal Stents, Bioabsorbable Stents); Delivery Mode (Self-expanding Stents, Balloon-expandable Stents); Product Type (Coronary Stents, Peripheral Stents, Neurovascular Stents); End-Use (Hospitals & Cardiac Centers, Ambulatory Surgery Centers, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Abbott Laboratories
  • Alvimedica
  • Asahi Intecc Co., Ltd.
  • B. Braun Melsungen AG
  • Biosensors International Group
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • C. R. Bard (now part of BD)
  • Cardinal Health (Cordis)
  • Cook Medical
  • Johnson & Johnson
  • Medinol Ltd.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • OrbusNeich Medical
  • STENTYS SA
  • Terumo Corporation
  • Terumo Interventional Systems

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Intravascular Stents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Burden of Cardiovascular Diseases Drives Demand for Intravascular Stents
    • Growing Aging Population With High Risk of Atherosclerosis Expands Stent Implantation Procedures
    • Technological Advancements in Drug-Eluting Stents (DES) Propel Market Differentiation and Outcomes
    • Expansion of Peripheral Artery Disease Treatment Strengthens Demand for Non-Coronary Stent Solutions
    • Rising Preference for Minimally Invasive Angioplasty Procedures Fuels Adoption of Stents
    • Increasing Use of Bioresorbable and Polymer-Free Stents Creates Product Innovation Opportunities
    • Growing Clinical Evidence Supporting Long-Term Outcomes of Newer-Generation Stents Enhances Physician Confidence
    • Development of Hybrid and Dual Therapy Stents Targets Complex Lesion Management
    • Integration of Advanced Imaging (IVUS, OCT) With PCI Procedures Drives Accurate Stent Placement
    • Expansion of Interventional Cardiology Programs in Emerging Markets Unlocks New Patient Segments
    • Surge in Transradial Access Procedures Enhances Demand for Deliverable, Flexible Stent Designs
    • Rising Prevalence of Diabetes and Comorbidities Fuels Need for Advanced Coated and Customized Stents
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Intravascular Stents Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Intravascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Intravascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Intravascular Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Drug Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Bare Metal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Bare Metal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Bare Metal Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Bioabsorbable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Bioabsorbable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Bioabsorbable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals & Cardiac Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals & Cardiac Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals & Cardiac Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Self-expanding Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Self-expanding Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Self-expanding Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Balloon-expandable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Balloon-expandable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Balloon-expandable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Coronary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Peripheral Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Peripheral Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Peripheral Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Neurovascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Neurovascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Neurovascular Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • JAPAN
    • Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • CHINA
    • Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 74: China Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • EUROPE
    • Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Intravascular Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Intravascular Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Intravascular Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • FRANCE
    • Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 101: France Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 107: France Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: France 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • GERMANY
    • Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Germany 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Germany 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 125: Italy Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Italy Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Italy 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Italy 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Italy 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 137: UK Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: UK 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: UK 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: UK 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 149: Spain Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Spain Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Spain 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Spain 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 155: Spain Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Spain 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 158: Spain Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Spain Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Spain 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 161: Russia Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Russia Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Russia 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Russia 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 167: Russia Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Russia Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Russia 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 170: Russia Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Russia Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Russia 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Europe Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Europe 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Europe 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Europe 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Europe Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Europe 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 186: Asia-Pacific Historic Review for Intravascular Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Asia-Pacific 15-Year Perspective for Intravascular Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Asia-Pacific 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Asia-Pacific 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Asia-Pacific Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Asia-Pacific 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 200: Australia Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Australia Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Australia 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Australia 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 206: Australia Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Australia Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Australia 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 209: Australia Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Australia Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Australia 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • INDIA
    • Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 212: India Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: India Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: India 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 215: India Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: India Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: India 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 218: India Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: India Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: India 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 221: India Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: India Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: India 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 224: South Korea Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: South Korea Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: South Korea 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: South Korea 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: South Korea Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: South Korea 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 233: South Korea Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: South Korea Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: South Korea 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Asia-Pacific Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Asia-Pacific Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 248: Latin America Recent Past, Current & Future Analysis for Intravascular Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 249: Latin America Historic Review for Intravascular Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Latin America 15-Year Perspective for Intravascular Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Latin America 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Latin America 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Latin America Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Latin America 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 260: Latin America Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Latin America Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Latin America 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 263: Argentina Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Argentina Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Argentina 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Argentina 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Argentina Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Argentina 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 272: Argentina Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Argentina Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Argentina 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 275: Brazil Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Brazil Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Brazil 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Brazil 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Brazil Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Brazil 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 284: Brazil Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Brazil Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Brazil 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 287: Mexico Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Mexico Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Mexico 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Mexico 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Mexico Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Mexico 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 296: Mexico Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Mexico Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Mexico 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Latin America Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Latin America 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Latin America 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Latin America 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Latin America Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Rest of Latin America 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 311: Middle East Recent Past, Current & Future Analysis for Intravascular Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 312: Middle East Historic Review for Intravascular Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Middle East 15-Year Perspective for Intravascular Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 316: Middle East 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 319: Middle East 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Middle East Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 322: Middle East 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 323: Middle East Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Middle East Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 325: Middle East 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 326: Iran Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Iran Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 328: Iran 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 331: Iran 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 332: Iran Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Iran Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 334: Iran 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 335: Iran Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Iran Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 337: Iran 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 338: Israel Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Israel Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 340: Israel 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Israel Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 343: Israel 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 344: Israel Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Israel Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 346: Israel 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 347: Israel Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Israel Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 349: Israel 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Saudi Arabia Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 352: Saudi Arabia 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 355: Saudi Arabia 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Saudi Arabia Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 358: Saudi Arabia 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Saudi Arabia Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 361: Saudi Arabia 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 362: UAE Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 363: UAE Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 364: UAE 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 365: UAE Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 366: UAE Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 367: UAE 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 368: UAE Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 369: UAE Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 370: UAE 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 371: UAE Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 372: UAE Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 373: UAE 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Rest of Middle East Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 376: Rest of Middle East 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Rest of Middle East Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 379: Rest of Middle East 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Middle East Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 382: Rest of Middle East 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Rest of Middle East Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 385: Rest of Middle East 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • AFRICA
    • Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 386: Africa Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Africa Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 388: Africa 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 389: Africa Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Africa Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 391: Africa 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 392: Africa Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Africa Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 394: Africa 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 395: Africa Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Africa Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 397: Africa 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제